Ctsdtm1Cptr
Targeted Allele Detail
|
Symbol: |
Ctsdtm1Cptr |
Name: |
cathepsin D; targeted mutation 1, Cristoph Peters |
MGI ID: |
MGI:2182078 |
Synonyms: |
Cat D-, CD-, CDKO, CTSD- |
Gene: |
Ctsd Location: Chr7:141929647-141941564 bp, - strand Genetic Position: Chr7, 87.93 cM
|
Alliance: |
Ctsdtm1Cptr page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:28201
|
Parent Cell Line: |
E14.1 (ES Cell)
|
Strain of Origin: |
129P2/OlaHsd
|
|
Allele Type: |
|
Targeted (Null/knockout) |
Mutation: |
|
Insertion
|
|
|
Mutation details: Exon 4 was disrupted by the insertion of a neomycin selection cassette, which altered the reading frame. One of the two active site aspartic acid residues and half of the proteinase region were downstream of the frameshift mutation. A lack of transcript in homozygous mutant mice was determined by Northern blot analysis of total kidney RNA. Western blot analysis of fibroblasts obtained from homozygous mutant embryos showed an absence of encoded protein. Proteinase activity was shown to be ablated in homozygous mutant mice by assaying hemoglobin degradation.
(J:28201)
|
|
|
Key: |
hm |
homozygous |
ht |
heterozygous |
tg |
involves transgenes |
√ |
phenotype observed |
cn |
conditional genotype |
cx |
complex: > 1 genome feature |
ot |
other: hemizygous, indeterminate,... |
N |
normal phenotype |
|
Genotype/ Background: |
| Allelic Composition | Genetic Background | Cell Line(s) |
---|
Loading... | | | either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd) | |
|
Phenotypes: |
Affected Systems |
|
|
behavior/neurological
|
√
|
decreased food intake
|
√
|
ataxia
|
√
|
bradykinesia
|
√
|
seizures
|
√
|
tonic seizures
|
√
|
cellular
|
√
|
cellular phenotype
|
N
|
increased forebrain apoptosis
|
√
|
lysosomal protein accumulation
|
√
|
digestive/alimentary system
|
√
|
abnormal intestinal mucosa morphology
|
√
|
abnormal crypts of Lieberkuhn morphology
|
√
|
abnormal ileum morphology
|
√
|
endocrine/exocrine glands
|
√
|
abnormal crypts of Lieberkuhn morphology
|
√
|
thymus hypoplasia
|
√
|
growth/size/body
|
√
|
decreased body weight
|
√
|
hematopoietic system
|
√
|
thymus hypoplasia
|
√
|
decreased lymphocyte cell number
|
√
|
decreased double-positive T cell number
|
√
|
abnormal microglial cell morphology
|
√
|
abnormal spleen white pulp morphology
|
√
|
abnormal spleen B cell follicle morphology
|
√
|
homeostasis/metabolism
|
√
|
abnormal thrombosis
|
√
|
immune system
|
√
|
thymus hypoplasia
|
√
|
decreased lymphocyte cell number
|
√
|
decreased double-positive T cell number
|
√
|
abnormal microglial cell morphology
|
√
|
abnormal spleen white pulp morphology
|
√
|
abnormal spleen B cell follicle morphology
|
√
|
abnormal antigen presentation
|
√
|
mortality/aging
|
√
|
premature death
|
√
|
nervous system
|
√
|
seizures
|
√
|
tonic seizures
|
√
|
increased forebrain apoptosis
|
√
|
abnormal microglial cell morphology
|
√
|
retina photoreceptor degeneration
|
√
|
vision/eye
|
√
|
abnormal retina morphology
|
√
|
retina photoreceptor degeneration
|
√
|
blindness
|
√
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
Key: |
√ |
disease model |
|
 |
expected model not found |
|
Models:
|
Human Diseases |
IDs
neuronal ceroid lipofuscinosis 10
Close
|
√
|
|
|
|
|
Original: |
J:28201 Saftig P, et al., Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO J. 1995 Aug 1;14(15):3599-608 |
All: |
40 reference(s) |
|